Moderna confirms FDA delayed Covid-19 vaccine in adolescents to review myocarditis risk

The drugmaker also said it would delay seeking authorization of its vaccine for younger children pending the outcome of the FDA’s review

from mint - Science https://ift.tt/3BwusYp
https://ift.tt/eA8V8J